4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001209191-16-104240
CIK 0001274792operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 11:13 AM ET
Size
6.9 KB
Accession
0001209191-16-104240
Insider Transaction Report
Form 4
PORTER MICHAEL E
Director
Transactions
- Purchase
Common Stock
2016-02-29$5.61/sh+10,000$56,100→ 709,448 total - Purchase
Common Stock
2016-03-01$6.60/sh+10,000$66,000→ 719,448 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.60 to $5.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $6.46 to $6.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 11:13 AM ET
- Size
- 6.9 KB